Platelet Protein-Related Abnormalities in Response to Acute Hypoglycemia in Type 2 Diabetes
Open Access
- 30 March 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 12, 651009
Abstract
Introduction: Patients with severe COVID-19 infections have coagulation abnormalities indicative of a hypercoagulable state, with thromboembolic complications and increased mortality. Platelets are recognized as mediators of inflammation, releasing proinflammatory and prothrombotic factors, and are hyperactivated in COVID-19 infected patients. Activated platelets have also been reported in type 2 diabetes (T2D) patients, putting these patients at higher risk for thromboembolic complications of COVID-19 infection. Methods: A case-control study of T2D (n=33) and control subjects (n=30) who underwent a hyperinsulinemic clamp to induce normoglycemia in T2D subjects: T2D: baseline glucose 7.5 ± 0.3mmol/l (135.1 ± 5.4mg/dl), reduced to 4.5 ± 0.07mmol/l (81 ± 1.2mg/dl) with 1-hour clamp; Controls: maintained at 5.1 ± 0.1mmol/l (91.9 ± 1.8mg/dl). Slow Off-rate Modified Aptamer (SOMA)-scan plasma protein measurement was used to determine a panel of platelet proteins. Results: Prothrombotic platelet proteins were elevated in T2D versus controls: platelet factor 4 (PF4, pConclusion: T2D patients have platelet hyperactivation, placing them at higher risk for thromboembolic events. When infected with COVID-19, this risk may be compounded, and their propensity for a more severe COVID-19 disease course increased. Clinical Trial Registration: https://clinicaltrials.gov/ct2/show/NCT03102801, identifier NCT03102801.Keywords
This publication has 26 references indexed in Scilit:
- Fibrinolysis and the control of blood coagulationBlood Reviews, 2015
- Plasminogen Activator Inhibitor-1 and Thrombotic Cerebrovascular DiseasesStroke, 2012
- Gender Dependence for a Subset of the Low-Abundance Signaling Proteome in Human PlateletsHuman Genomics and Proteomics, 2010
- Glucose Regulates Diacylglycerol Intracellular Levels and Protein Kinase C Activity by Modulating Diacylglycerol Kinase Subcellular LocalizationJournal of Biological Chemistry, 2007
- High glucose‐induced activation of the polyol pathway and changes of gene expression profiles in immortalized adult mouse Schwann cells IMS32Journal of Neurochemistry, 2006
- Activation of the hexosamine pathway causes oxidative stress and abnormal embryo gene expression: Involvement in diabetic teratogenesisBirth Defects Research Part A: Clinical and Molecular Teratology, 2004
- Role of platelets in coronary thrombosis and reperfusion of ischemic myocardiumCardiovascular Research, 2004
- Platelets and strokeVascular Medicine, 1999
- Platelets and strokeVascular Medicine, 1999
- Covalent Heparin Cofactor II-Heparin and Heparin Cofactor II-Dermatan Sulfate ComplexesJournal of Biological Chemistry, 1998